ebomi
Colour theme
Sign in
Insider · CIK 0001311210

Machado Patrick

CIK 0001311210 Name as filed on the most recent filing

Filed as Machado Patrick (17)· Machado Clarence Patrick (40)

117 transaction lines · from 57 filings · filed 2007-03-20 to 2021-03-24 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

117 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2021-03-24 Adverum Biotechnologies, Inc.
ADVM 		P, Open-market purchase 10,000 acquired 9.92 99,196.00 Form 4, filing 0001209191-21-022933
2021-01-15 Adverum Biotechnologies, Inc.
ADVM 		P, Open-market purchase 10,000 acquired 11.52 115,174.00 Form 4, filing 0001209191-21-004143
2019-06-19 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 4,957 acquired 8.17 40,495.22 Form 4, filing 0001104659-19-036422
2019-06-18 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,706 acquired 8.21 55,060.95 Form 4, filing 0001104659-19-036422
2019-06-17 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,541 acquired 8.53 55,824.82 Form 4, filing 0001104659-19-036422
2019-06-14 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,144 acquired 7.91 56,514.04 Form 4, filing 0001104659-19-035731
2019-06-13 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,367 acquired 7.95 58,542.60 Form 4, filing 0001104659-19-035731
2019-06-12 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,500 acquired 8.30 62,244.00 Form 4, filing 0001104659-19-035731
2019-06-11 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,189 acquired 8.58 61,693.84 Form 4, filing 0001104659-19-034834
2019-06-10 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,500 acquired 8.35 62,594.25 Form 4, filing 0001104659-19-034834
2019-06-07 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,649 acquired 7.96 52,959.28 Form 4, filing 0001104659-19-034834
2019-06-06 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,082 acquired 8.00 56,621.30 Form 4, filing 0001104659-19-034349
2019-06-05 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,540 acquired 8.02 52,418.10 Form 4, filing 0001104659-19-034349
2019-06-04 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 7,500 acquired 7.59 56,910.75 Form 4, filing 0001104659-19-034349
2019-06-04 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 2,424,242 acquired 8.25 19,999,996.50 Form 4, filing 0001104659-19-034355
2019-06-03 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,424 acquired 7.71 41,814.70 Form 4, filing 0001104659-19-033505
2019-05-31 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,071 acquired 7.70 39,042.14 Form 4, filing 0001104659-19-033505
2019-05-30 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,951 acquired 7.97 55,417.54 Form 4, filing 0001104659-19-033505
2019-05-30 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 300 acquired 8.91 2,671.98 Form 4, filing 0001104659-19-033505
2019-05-29 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,882 acquired 7.55 51,983.19 Form 4, filing 0001104659-19-032476
2019-05-28 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 3,807 acquired 7.68 29,244.61 Form 4, filing 0001104659-19-032476
2019-05-24 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 3,796 acquired 7.70 29,233.38 Form 4, filing 0001104659-19-032476
2019-05-23 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 4,802 acquired 7.76 37,252.00 Form 4, filing 0001104659-19-031532
2019-05-22 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,033 acquired 8.06 40,557.93 Form 4, filing 0001104659-19-031532
2019-05-21 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 9,995 acquired 8.52 85,108.42 Form 4, filing 0001104659-19-031532
2019-05-20 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 8,285 acquired 7.98 66,141.64 Form 4, filing 0001104659-19-030617
2019-05-20 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 1,715 acquired 8.39 14,383.19 Form 4, filing 0001104659-19-030617
2019-05-17 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 6,200 acquired 7.36 45,641.30 Form 4, filing 0001104659-19-030617
2019-05-16 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 5,408 acquired 6.79 36,718.16 Form 4, filing 0001104659-19-030617
2019-03-18 Axovant Sciences Ltd.
AXON 		P, Open-market purchase 6,666,667 acquired 1.50 10,000,000.50 Form 4, filing 0001104659-19-016043
2018-12-18 Axovant Sciences Ltd.
AXON 		P, Open-market purchase 10,000,000 acquired 1.00 10,000,000.00 Form 4, filing 0001104659-18-073900
2018-10-01 Urovant Sciences Ltd.
UROV 		P, Open-market purchase 2,678,571 acquired 14.00 37,499,994.00 Form 4, filing 0001104659-18-060346
2018-06-05 Axovant Sciences Ltd.
AXON 		P, Open-market purchase 14,285,714 acquired 1.75 24,999,999.50 Form 4, filing 0001104659-18-038769
2018-04-02 Myovant Sciences Ltd.
MYOV 		P, Open-market purchase 1,110,015 acquired 20.27 22,500,004.05 Form 4, filing 0001104659-18-022435
2016-09-15 Scynexis Inc
SCYX 		P, Open-market purchase 40,000 acquired 2.94 117,600.00 Form 4, filing 0001628280-16-019607
2016-06-24 Scynexis Inc
SCYX 		P, Open-market purchase 20,000 acquired 2.39 47,800.00 Form 4, filing 0001628280-16-017407
2016-01-19 Medivation, Inc.
MDVN 		S, Open-market sale 37,021 disposed 36.62 1,355,709.02 Form 4, filing 0001209191-16-092938
2016-01-19 Medivation, Inc.
MDVN 		S, Open-market sale 23,087 disposed 37.50 865,762.50 Form 4, filing 0001209191-16-092938
2016-01-19 Medivation, Inc.
MDVN 		S, Open-market sale 7,942 disposed 38.62 306,720.04 Form 4, filing 0001209191-16-092938
2016-01-19 Medivation, Inc.
MDVN 		S, Open-market sale 6,950 disposed 39.19 272,370.50 Form 4, filing 0001209191-16-092938
2015-12-29 Chimerix Inc
CMRX 		P, Open-market purchase 10,000 acquired 7.08 70,846.00 Form 4, filing 0001209191-15-087355
2015-09-25 Medivation, Inc.
MDVN 		S, Open-market sale 22,236 disposed 41.63 925,684.68 Form 4, filing 0001209191-15-072348
2015-09-25 Medivation, Inc.
MDVN 		S, Open-market sale 20,464 disposed 42.68 873,403.52 Form 4, filing 0001209191-15-072348
2015-09-25 Medivation, Inc.
MDVN 		S, Open-market sale 17,680 disposed 43.92 776,505.60 Form 4, filing 0001209191-15-072348
2015-09-25 Medivation, Inc.
MDVN 		S, Open-market sale 11,600 disposed 40.82 473,512.00 Form 4, filing 0001209191-15-072348
2015-06-04 Medivation, Inc.
MDVN 		S, Open-market sale 16,600 disposed 116.12 1,927,592.00 Form 4, filing 0001209191-15-051143
2015-06-04 Medivation, Inc.
MDVN 		S, Open-market sale 9,600 disposed 119.06 1,142,976.00 Form 4, filing 0001209191-15-051143
2015-06-04 Medivation, Inc.
MDVN 		S, Open-market sale 6,600 disposed 118.38 781,308.00 Form 4, filing 0001209191-15-051143
2015-06-04 Medivation, Inc.
MDVN 		S, Open-market sale 2,900 disposed 117.10 339,590.00 Form 4, filing 0001209191-15-051143
2015-06-04 Medivation, Inc.
MDVN 		S, Open-market sale 300 disposed 120.04 36,012.00 Form 4, filing 0001209191-15-051143

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 37
  • Open-market sale 80
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Machado Patrick, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001311210

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.